However, in diagnosis human BCP-ALL samples, expression of ST6GAL1 showed a more than 300-fold variability between the highest and lowest levels with no correlation (Figure 2C) between expression levels and mutation-associated risk category (27–29). The gene discussed is ST6GAL1; the disease is acute lymphoblastic leukemia.